These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Lipoproteins lipase and its effect on very low density lipoproteins]. Polonovski J; Glangeaud-Freudenthal MC Expos Annu Biochim Med; 1982; 35():13-37. PubMed ID: 7037450 [No Abstract] [Full Text] [Related]
3. Lipoproteins and lipoprotein lipase activities in obese type 2 diabetics: studies of the relationship between low density lipoproteins and the skeletal muscle lipoprotein lipase. Vessby B; Lithell H Monogr Atheroscler; 1985; 13():124-9. PubMed ID: 4088275 [No Abstract] [Full Text] [Related]
4. [Hypertriglyceridemia in a deficiency of lipoprotein lipase and hepatic lipase]. Ikeda Y; Takagi A Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):783-90. PubMed ID: 3270893 [No Abstract] [Full Text] [Related]
5. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975 [TBL] [Abstract][Full Text] [Related]
6. Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation. Karpe F; Bickerton AS; Hodson L; Fielding BA; Tan GD; Frayn KN Biochem Soc Trans; 2007 Jun; 35(Pt 3):472-6. PubMed ID: 17511631 [TBL] [Abstract][Full Text] [Related]
7. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C. Catapano AL; Capurso A; Kinnunen PK Artery; 1981; 9(2):87-95. PubMed ID: 7295047 [TBL] [Abstract][Full Text] [Related]
8. Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference. Niu YG; Evans RD Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1106-16. PubMed ID: 18780778 [TBL] [Abstract][Full Text] [Related]
14. Genetic epistasis in the VLDL catabolic pathway is associated with deleterious variations on triglyceridemia in obese subjects. Brisson D; St-Pierre J; Santuré M; Hudson TJ; Després JP; Vohl MC; Gaudet D Int J Obes (Lond); 2007 Aug; 31(8):1325-33. PubMed ID: 17342071 [TBL] [Abstract][Full Text] [Related]
15. Modern management of hyperlipidemia. Grundy SM Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992 [No Abstract] [Full Text] [Related]